Traders sold shares of Humana Inc (NYSE:HUM) on strength during trading on Monday. $155.54 million flowed into the stock on the tick-up and $204.64 million flowed out of the stock on the tick-down, for a money net flow of $49.10 million out of the stock. Of all stocks tracked, Humana had the 17th highest net out-flow for the day. Humana traded up $0.69 for the day and closed at $254.00
A number of brokerages recently weighed in on HUM. Zacks Investment Research reissued a “hold” rating and issued a $306.00 price target on shares of Humana in a research note on Monday, December 31st. ValuEngine cut Humana from a “hold” rating to a “sell” rating in a research note on Thursday. Credit Suisse Group dropped their price target on Humana from $390.00 to $352.00 and set an “outperform” rating on the stock in a research note on Thursday, February 7th. Barclays reissued a “buy” rating and issued a $351.00 price target on shares of Humana in a research note on Sunday, January 6th. Finally, Stephens began coverage on Humana in a research note on Monday, January 14th. They issued an “overweight” rating and a $336.00 price target on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the stock. Humana currently has a consensus rating of “Buy” and a consensus target price of $355.06.
The firm has a market cap of $34.36 billion, a PE ratio of 17.46, a PEG ratio of 1.07 and a beta of 0.93. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.43.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 0.87%. This is a positive change from Humana’s previous quarterly dividend of $0.50. The ex-dividend date is Thursday, March 28th. Humana’s payout ratio is currently 3.44%.
In related news, insider Christopher H. Hunter sold 15,586 shares of the firm’s stock in a transaction that occurred on Monday, February 25th. The stock was sold at an average price of $305.24, for a total value of $4,757,470.64. Following the transaction, the insider now directly owns 28,100 shares of the company’s stock, valued at approximately $8,577,244. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Roy A. Beveridge sold 8,278 shares of the firm’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $307.16, for a total value of $2,542,670.48. Following the completion of the transaction, the insider now directly owns 12,409 shares in the company, valued at $3,811,548.44. The disclosure for this sale can be found here. 0.54% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of HUM. Moody National Bank Trust Division bought a new position in shares of Humana in the 4th quarter valued at approximately $30,000. We Are One Seven LLC bought a new position in shares of Humana in the 4th quarter valued at approximately $31,000. Proficio Capital Partners LLC raised its stake in shares of Humana by 81.4% in the 4th quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 48 shares in the last quarter. Exane Asset Management bought a new position in shares of Humana in the 4th quarter valued at approximately $43,000. Finally, Sontag Advisory LLC bought a new position in shares of Humana in the 4th quarter valued at approximately $47,000. 94.52% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Traders Sell Humana (HUM) on Strength (HUM)” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2019/04/15/traders-sell-humana-hum-on-strength-hum-2.html.
About Humana (NYSE:HUM)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Story: What is the outlook for the FAANG stocks?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.